Diagnostic and treatment of eye cancer

Eye cancer is a term used to define many types of tumors that can occurs in various parts of the eye. Eye cancer occurs when healthy cells in or around the eye change and grow uncontrollably, forming a mass called a tumor. High-throughput sequencing is helping to deeply understand the cancer genome, and the mechanisms that cause tumor progression and affect treatment response. The NGS (Next Generation Sequencing) technology is used for tumor profiling and assess signalling pathways within the tumor. The gene changes that make eye cancer cells, are different from normal cells and play an important role in treating eye melanomas, lymphomas, and other eye cancers in the future. There are different types of biological therapies to extravagance eye cancers.

The NITRO trial a type of biological therapy called ranibizumab for uveal melanoma. Ranibizumab is a monoclonal antibody. It works as targeting a protein on the cancer cell called vascular endothelial growth factor (VEGF).

    Related Conference of Diagnostic and treatment of eye cancer

    May 09-10, 2024

    7th International Eye and Vision Congress

    Barcelona, Spain
    May 16-17, 2024

    8th World Congress on Eye and Vision

    Rome, Italy
    June 13-14, 2024

    9th International Conference on Eye and Vision

    Barcelona, Spain
    September 12-13, 2024

    5th International Conference on Optometry

    Paris, France
    October 10-11, 2024

    34th World Congress on Ophthalmology and Optometry

    Madrid, Spain
    October 10-11, 2024

    10th Global Ophthalmology Meeting

    Madrid, Spain
    October 17-18, 2024

    24th Global Ophthalmologists Annual Meeting

    London, UK

    Diagnostic and treatment of eye cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in